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Altered cytokine proﬁles and imbalanced frequencies of CD4+ T helper cell subsets are thought to be
linked with HIV-1/AIDS pathogenesis, but the causes need to be further clariﬁed. Histamine, a biogenic
amine with many functions, shows enhancement in HIV-1 infected individuals, which are considered to
link with disease progression, but is poorly understood. This study investigated histamine-assisted HIV-1
modulation of dendritic cell (DC) functions. Histamine and HIV-1 showed a synergistic role in induction
of interleukin-10; histamine inhibited HIV-1-induced IL-12 production from MDDCs (monocyte-derived
DCs); notably, histamine augmented HIV-1-induced MDDC functional polarization and skewed naïve T
cell differentiation toward regulatory T cells (Tregs). The results indicate the novel role of histamine in
HIV-1-induced DC functional regulation, which promoted Treg cell differentiation and up-regulated
immunosuppressive factors. These ﬁndings help to bridge the correlation between elevated histamine
and increased Treg cell frequency in HIV-1 infected individuals, and add to our understanding of HIV-1-
induced immunosuppression.
& 2013 Elsevier Inc. All rights reserved.Introduction
Numerous efforts have been made to understand HIV-1/AIDS
pathogenesis. The altered cytokine proﬁle and imbalanced frequencies
of CD4+ T helper cell subsets observed in HIV-1 infected individuals
are thought to be linked with impaired immune responses and disease
progression of lentiviral infections (Cecchinato et al., 2008; Clerici and
Shearer, 1994; Dandekar et al., 2010; Elhed and Unutmaz, 2010;
Gaardbo et al., 2012; Hartigan-O'Connor et al., 2012; Li et al., 2012b;
Macal et al., 2008; McKinnon and Kaul, 2012; Prendergast et al., 2010;
Rubbo et al., 2011; Singh et al., 2012; Sun et al., 2012; Williams et al.,
2012). Regulatory T cells (Tregs) have a markedly increased frequency
in the peripheral blood and mucosal tissues of HIV-1-infected patients
and SIV (Simian Immunodeﬁciency Virus)-infected macaques (Li et al.,
2012a; Shaw et al., 2011). The higher frequency of circulating Tregsll rights reserved.
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ciences, Hefei Road no. 411,could be largely normalized with highly active antiretroviral therapy
(Presicce et al., 2011). Treg cell frequency is inversely related to CD4+ T
cell counts and positively correlated with plasma viral load (Li et al.,
2011). HIV-1-driven accumulation and survival maintenance of Treg
cells in lymphoid tissues of infected individuals was observed to be
associated with disease progression (Nilsson et al., 2006), suggesting
Treg cells might contribute to immunosuppression in HIV-1 infection.
The exact roles of Treg cells in HIV-1 pathogenesis remain contro-
versial (Chevalier andWeiss, 2012; Imamichi and Lane, 2012; Moreno-
Fernandez et al., 2012). The loss of IL-17-producing CD4+ T helper cells
(Th17)/Treg cell balance appears to inﬂuence the outcome of early viral
infection, and compromise host immunity because of lack of local
control of microbial translocation (Kanwar et al., 2010; Raffatellu et al.,
2008). The imbalance of Th1/Th2 cell response has been widely
described in HIV-1 infected persons (Clerici and Shearer, 1994; Favre
et al., 2010; Li et al., 2012b; Rubbo et al., 2011). Investigating causes of
imbalance among T helper cell subsets would increase our under-
standing of immune dysfunction in HIV-1 infection.
Histamine is a biogenic amine, with a wide range of activities,
but is best known for its roles in triggering local inﬂammation
responses and in allergic disorders (Ferstl et al., 2012; O'Mahony
et al., 2011; Schneider et al., 2010). Histamine modulates the
functions of multiple host immune cells to control the balance
between immunity and tolerance (O'Mahony et al., 2011; Schneider
R.-R. Zhai et al. / Virology 442 (2013) 163–172164et al., 2010). Histamine has been shown to inﬂuence dendritic cell
(DC) involvement in various inﬂammatory responses (Baumer et al.,
2008; Ferstl et al., 2012; Geng et al., 2012; Mazzoni et al., 2003;
McIlroy et al., 2006; O'Mahony et al., 2011; Simon et al., 2011).
Elevated histamine levels have been observed in HIV-1-
infected individuals (Pedersen et al., 1991). Human basophils and
mast cells strongly express the high-afﬁnity FcεR1 IgE receptors.
These FcεR1+ cells can be activated by HIV-1 to induce histamine
release following IgE-mediated cross-linking of FcεR1 receptors
(de Paulis et al., 2002; Marone et al., 2001; Patella et al., 2000;
Pedersen et al., 1991; Taub et al., 2004). The HIV-1 envelope
glycoprotein gp120 has been reported as a viral super-antigen, via
interacting with the VH3 region of IgE, to induce the release of
histamine, IL-4 and IL-13 from human FcεR1+ cells (Florio et al.,
2000; Marone et al., 2001; Patella et al., 2000). In addition,
multiple cytokines, such as IL-4, TNF-α, IFN-γ, IL-1, IL-3, colony
stimulating factor (CSF) and granulocyte-macrophage-CSF (GM-
CSF) can also induce histamine release in AIDS patients (Pedersen
et al., 1990).
The relationship between histamine and AIDS disease progres-
sion is poorly understood, but increased histamine release is
inversely correlated with the number of CD4+ T lymphocytes
(Pedersen et al., 1991). A recent report showed that histamine
increased the production of IFN-γ by HIV-1 gp120 peptide speciﬁc
cytotoxic CD8+ T lymphocytes, and IFN-γ production was nega-
tively correlated with total IgE level in those HIV-1 infected
individuals (Hanzlikova et al., 2012). Given the multiple functions
of histamine in regulating immunity and tolerance, knowing more
about the immune-regulation of histamine in HIV-1 infection
will increase our understanding of immunosuppression and viral
pathogenesis.
This current study found that histamine assisted HIV-1 inﬂu-
enced differentiation of naïve T cells toward Treg cells. Co-
activated monocyte-derived DCs (MDDCs) (i.e., stimulated by both
histamine and HIV-1) had altered cytokine production that was
biased toward immunosuppression. Our ﬁndings demonstrate a
novel role of histamine, participating in HIV-1-induced immuno-
regulation that helps account for the correlation of elevated
histamine with increased Treg cell frequency in HIV-1 infected
individuals. The results strengthen our understanding of HIV-1-
induced immunosuppression and viral pathogenesis.Results
Histamine assists in HIV-1-induced MDDC activation
The expression of histamine receptors was detected. Four
known histamine receptors, H1R, H2R, H3R and H4R (Ferstl
et al., 2012; O'Mahony et al., 2011), were ampliﬁed with real-
time PCR. MDDCs expressed H1R, H2R, and H4R, but not H3R
(Fig. 1A).
The effects of treatment with histamine and/or HIV-1 on MDDC
phenotype were tested. The CCR5-tropic HIV-1 strain JRFL was
used as the representative for stimulating MDDCs. The 10 μM
concentration of histamine was selected due to being within the
physiological range (Mazzoni et al., 2001), and this concentration
is sufﬁcient to activate histamine receptors (MacGlashan, 2003).
Immature MDDCs were treated for 48 h, and cell phenotypes were
monitored by detecting the expression of CD83, CD86, and HLA-DR
on the cell surface by ﬂow cytometry. Compared with treatment
by cell culture medium, HIV-1/JRFL or histamine alone increased
CD83, CD86, and HLA-DR only slightly or not at all. Co-treatment
with histamine and HIV-1 increased expression of these markers,
especially of CD83 and CD86, suggesting activation of the MDDCs
(Fig. 1B and C). When different HIV-1 strains, such as HIV-1/ADA(CCR5 tropism) and HIV-1/NL4-3(CXCR4 tropism), were used as
the viral representatives, similar results were observed (Fig. S1).
Histamine treatment did not affect the susceptibility of MDDCs to
HIV-1 infection (data not shown), and these treatments did not
alter cell viability, as evaluated by PI-exclusion staining (Fig. S2).
Together, these results showed that histamine or HIV-1 alone did
not obviously activate MDDCs, but co-treatment with both hista-
mine and HIV-1 promoted MDDC maturation.
Histamine alters HIV-1-induced MDDC cytokine proﬁles
The effects of histamine on HIV-1-induced MDDC cytokine
production were analyzed. Cytokine expression was measured by
both protein secretion and mRNA expression. Both histamine and
HIV-1 strongly induced IL-10 production (Fig. 2A and B), the anti-
inﬂammatory cytokine primarily involved in immunosuppression.
It was clear that histamine and HIV-1 had a synergistic effect
on IL-10 induction, which suggested the potential assistance
of histamine in HIV-1-induced immunosuppression and Th2
response polarization in infected individuals (Clerici and Shearer,
1994; Li et al., 2012b; Rubbo et al., 2011). The co-stimulation of
MDDCs by histamine and HIV-1 enhanced TGF-β production
(Fig. 2A and B). The enhancements of IL-6 production in HIV-1-
contained samples were observed, proving HIV-1-induced Th2
cell response skewing, but histamine did not have obvious effect
on HIV-1-induced IL-6 expression (Fig. 2A and B). However,
histamine-treatment hampered HIV-1-induced up-regulation of
IL-12 (Fig. 2A and B), suggesting the potential contribution of
histamine to suppression of the Th1 cell response. Together,
these data showed that histamine altered HIV-1-induced cytokine
proﬁles of MDDCs, and suggested a possible contribution of
histamine to immunosuppression and the imbalanced Th1/Th2
cell response during HIV-1 infection.
Co-stimulation enhances MDDC-promoted CD4+ T cell proliferation
To further determine the effect of histamine on MDDC function,
the ability of MDDC to drive T cell proliferation was evaluated.
Histamine or/and HIV-1 treated-MDDCs were co-cultured with
CFSE-stained allogeneic CD4+ T cells for 6 days (Fig. 3A), and T cell
proliferation was determined by monitoring CFSE intensity. Treat-
ment of MDDCs with histamine or HIV-1 alone did not signiﬁ-
cantly drive the proliferation of CD4+CD45RA+ naïve T cells,
however, MDDCs co-stimulated with both histamine and HIV-1
resulted in increases in the proliferation rate of naïve T cells
(Fig. 3B). Signiﬁcant increases in T cell proliferation were also
observed if resting CD4+ T cells were included in mixed culture
with co-treated MDDCs (Fig. 3C). Resting CD4+ T cells were
isolated from healthy PBMCs with anti-CD4-antibodies-coated
magnetic microbeads, about 28–57% cells from 3 independent
donors showed the phenotype of CD4+CD45RA+ naïve T cell (Fig S3).
Together, these data demonstrated that co-stimulation with hista-
mine and HIV-1 modulated MDDC-mediated promotion of CD4+ T
cell proliferation.
Histamine assists in HIV-1 modulation of MDDC effects on Treg cell
differentiation
To investigate differential effects on proliferation of T-cell subsets,
primed CD4+ CD45RA+ naïve T cells were isolated from co-culture
with treated-MDDCs, by using anti-CD3 antibody coated microbeads.
The Treg cell phenotype was detected by double staining with CD25
and Foxp3 (Fig. 4A). HIV-1-treatment increased CD25+ Foxp3+ Treg
cell labeling from 4.1% to 5.1% (Fig. 4B). Interestingly, although
histamine alone did not signiﬁcantly affect the ability of DCs for
driving Treg-cell differentiation, the addition of histamine during
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Fig. 1. Co-treatment with histamine and HIV-1 promotes MDDC activation. (A) Expression of MDDC histamine receptors was investigated by mRNA assay. Results from three
donors are shown. (B) MDDC activation was monitored by ﬂow cytometry. Immature MDDCs were treated with histamine and/or of HIV-1（4 ng of p24gag） for 48 h. Culture
medium treatment was used as a control. MDDC maturation was monitored by measuring the expression of HLA-DR, and co-stimulatory molecules of CD83 and CD86. The
values of MFI (mean ﬂuorescence intensity) are shown. (C) The MFI values from 5 independent donors were summarized and analyzed. The mean value of MFI from all
5 donors was indicated. *Po0.05 was considered signiﬁcant difference in paired t test.
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generation (Fig. 4B and C), as CD25+Foxp3+ cell-percentage showed
more than 2-fold increase.
Treg cell generationwas also evaluated with a functional assay of
T cell proliferation. Puriﬁed, MDDC-primed T cells were co-culturedwith CFSE-labeled allogeneic resting CD4+ T cells for 3 days;
phytohemagglutinin (PHA-P) was added to stimulate cell prolifera-
tion. As expected (Fig. 4D), naïve T cells primed by co-stimulated
MDDCs had a stronger inhibitory effect on PHA-P-stimulated T cell
proliferation, and naïve T cells primed by HIV-1-treated MDDCs
Fig. 2. Cytokine production by DCs treated with HIV-1 and/or histamine. Immature MDDCs were treated with histamine (10 μM) and/or HIV-1 (4 ng of p24gag), MDDCs
treated with culture medium alone were used as a control. (A) Cytokine production at the protein level was quantiﬁed at 48 hours post-treatment. (B) Relative production of
cytokines was measured by mRNA expression at 7 h post-treatment. One representative from ﬁve donors is shown. Data are mean7SD. *Po0.05, **Po0.01, ***Po0.001,
were considered signiﬁcant difference in paired t test.
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tent with a smaller percentage of Treg cells (Fig. 4D).
To investigate whether HIV-1 infection is required for driving T
cell differentiation, after 6 days of co-culture of treated-MDDCs
with CD4+CD45RA+ naïve T cells, anti-CD3- antibodies-coated
magnetic microbeads were used to separate the MDDCs (CD3-)
and T cells (CD3+) population, and viral infection in each popula-
tion was detected by measuring luciferase activity. There was no
HIV-1 replication in separated T cells, indicating the infection of T
cells might not be required for preferential skewing, while, in
separated MDDCs, HIV-1 showed a slight infection 6 days post
viral inoculation (Fig. S4).
Together, these data demonstrated that histamine augments
HIV-1 modulation of MDDC function to drive naïve T cell differentia-
tion in the direction of Treg cells. The results might suggest that of
histamine contributes to immunosuppression during HIV-1 infection.Histamine augments HIV-induced IDO expression in MDDCs via
binding with histamine receptor 2
The induction of IDO (Indoleamine 2,3-dioxygenase) and its
dependent tryptophan catabolism in DCs plays a critical role in
controlling Treg cell differentiation and the Th17/Treg cell balance
(Boasso et al., 2007b; Favre et al., 2010; Matteoli et al., 2010).
Cytokines such as IFN-γ, IFN-α and TGF-β, are strong inducers of
IDO (Boasso and Shearer, 2007; Pallotta et al., 2011). IDO expression
was thus measured in stimulated MDDCs. Both histamine and HIV-1
induced IDO expression in MDDCs, detected by both increased mRNA
expression (Fig. 5A) and protein synthesis (Fig. 5B). Again, a syner-
gistic effect of histamine and HIV-1 on IDO induction was observed
(Fig. 5A and B). Moreover, recombinant gp120 glycoprotein fromHIV-1/JRFL also induced IDO expression (Fig. 5A), indicating HIV-1
envelope protein may play responsible role for IDO induction.
MDDCs expressed mRNAs encoding histamine receptors including
H1R, H2R and H4R (Fig. 1A). To determine which receptor-mediated
signal was responsible for IDO induction, MDDCs were prior-blocked
with selective antagonists of histamine receptors, including pyrilamine
(for H1R), cimetidine (for H2R) and thioperamide (for both H3R and
H4R), respectively. Cimetidine, but not pyrilamine or thioperamide,
abolished IDO induction by histamine (Fig. 5C), indicating H2R-
mediated signaling was critical for IDO induction in MDDCs. The
treatments with individual receptor antagonists did not alter cell
viability, and the treatments with HIV-1 and/or histamine did not
affect histamine receptor expression (data not shown).
In addition to histamine, mast cells and basophils can degranu-
late to release other chemokines, cytokines and proteoglycans upon
stimulation (Prussin and Metcalfe, 2003). To investigate whether
other mediators could induce or promote HIV-1-induced-IDO
production in MDDCs, TNF-α and β-tryptase were used as repre-
sentative to stimulate MDDCs, and the induction of IDO mRNA was
detected. Treatment with the TNF-α/β-tryptase combination did not
induce IDO expression in MDDCs, and no synergetic role of TNF-α/β-
tryptase with HIV-1 on IDO-induction was observed (Fig. 5D). Taken
together, these data demonstrated that histamine induced IDO
expression via H2R-mediated signaling, and histamine exhibited a
synergistic effect with HIV-1 on IDO induction in MDDCs.
IDO inhibition compromises MDDCs-driven Treg-cell differentiation
An IDO inhibitor, 1-methyl-tryptophan (1-MT), was used to
determine whether increased IDO expression in treated-MDDCs
conferred the capacity to drive naïve T cells toward Treg cell
differentiation. Immature MDDCs were treated with histamine/HIV-1
Fig. 3. Activated MDDCs promote T cell proliferation. (A) Scheme for assessing T cell proliferation. Immature MDDCs were treated with histamine and/or HIV-1 and
co-cultured with CFSE-labeled CD4+ T lymphocytes for 6 days. T-cell populations were gated and analyzed by CFSE intensity. (B) Proliferation of CD4+CD45RA+ naïve T cells
upon stimulation with treated-MDDCs. Results from 3 independent donors are indicated. (C) Proliferation of resting CD4+ T cells upon stimulation with treated-MDDCs.
Results from 5 donors are shown, and the mean value is indicated. **Po0.01 was considered signiﬁcant difference in paired t test.
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with or without 1-MT (200 μM) (Fig. 6A). Treatment of MDDCs
with 1-MT compromised the capacity of HIV-1/histamine co-treated-
MDDCs to drive naïve CD4+ T cell differentiation toward Treg
cell development. The generation of Treg cells was demonstratedin a proliferation suppression assay of allogeneic resting CD4+ T
cells (Fig. 6B). Together, these results demonstrated that enhanced
expression of IDO in HIV-1/histamine co-treated-MDDCs skewed
cultured naive CD4+ T cells from proliferation toward differentiation
of Treg cells.
Fig. 4. Histamine assists in HIV-1 modulation of MDDC effects on Treg cell differentiation. (A) Scheme of the Treg cell differentiation assay. Immature MDDCs were treated as
above and co-cultured with CD4+CD45RA+ naïve T cells for 6 days. T cell populations were puriﬁed by using anti-CD3 speciﬁc antibody coated microbeads. (B) The Treg cell
phenotype was detected by immunostaining with CD25 and Foxp3. The percentage of double-positive cell population is indicated, and results from 2 independent donors are
summarized (C). (D) Functional assay of Treg cell for suppressing T cell proliferation. MDDC-primed T cells were co-cultured with CFSE-labeled allogeneic resting CD4+ T cells
for 3 days, PHA-P was used to stimulate cell proliferation, one representative out of 4 donors is shown.
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HIV-1 infection leads to immunodeﬁciency in humans, and
great efforts have been expended to understand HIV-1 viral
pathogenesis. Both increased histamine level and Treg cell fre-
quency are inversely correlated with CD4+ T-lymphocyte counts in
AIDS patients (Li et al., 2011; Pedersen et al., 1991), which suggests
that they contribute to disease progression. Their speciﬁc roles in
viral immuno-pathogenesis need to be investigated further in vivo
and in vitro.
These ﬁndings help explain the correlation of elevated hista-
mine with increased Treg cell frequency in HIV-1-infected indivi-
duals. Dendritic cells, the pivotal antigen presenting cells in host
immunity, can be targeted by histamine and HIV-1 for polarizing aTreg cell subset and altering their cytokine secretion. These
ﬁndings add to the understanding of the immunosuppression
observed in AIDS patients and HIV-1 immuno-pathogenesis. The
results support the conduct of in vivo investigations to indicate the
association of histamine and increased Treg cell frequency.
Increased histamine has been observed in many HIV-1 infected
individuals(Pedersen et al., 1991). Basophils from AIDS patients and
individuals with milder HIV-1 infection release greater amounts of
histamine in response to HIV-1 antigen than those from patients
with more advanced disease (Pedersen et al., 1991), suggesting a
correlation of histamine release with disease progression. HIV-1
gp120 could act as super-antigen to induce histamine release from
human FcεR1+ basophils and mast cells, through the interaction
with VH3 region of IgE (Florio et al., 2000; Patella et al., 2000).
Fig. 5. Histamine augments HIV-1-induced IDO expression in MDDCs via histamine receptor 2-mediated signaling. Immature MDDCs were treated with histamine and/or
HIV-1, or with recombinant gp120 glycoprotein (10 μg/mL). Culture medium was used as treatment control. IDO expression was measured at (A) 7 h post-treatment for
mRNA expression, and (B) 24 h post-treatment for protein production. Intracellular staining was measured by ﬂow cytometry assay, and percentage of cells with IDO
expression is shown. (C) Immature MDDCs were pre-treated with pyrilamine (50 μM), cimetidine (50 μM), and thioperamide (50 μM) for 1 h, before HIV-1 and/or histamine
treatment as above. IDO expression was measured at the mRNA level. (D) Immature MDDCs were treated with different stimuli as indicated for 7 h. IDO expression was
measured at the mRNA level. One representative from 3 donors was shown (C, D). Data are mean7SD (*Po0.05, **Po0.01, ***Po0.001, by the paired sample t-test).
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CD4+ T cell number and a positive correlation with the plasma viral
load (Pedersen et al., 1991). The potential contribution of enhanced
histamine level in vivo to disease progression and the related
mechanisms need further study.
HIV-1-infected individuals have increased IDO production,
which is considered to be the major driving force for the
tryptophan deﬁciency (Boasso et al., 2007a; Boasso and Shearer,
2007). IDO expression shows a strongly positive correlation with
plasma viral load (Boasso et al., 2007a). Multiple cytokines such as,
IFN-γ and IFN-α, and HIV-1 particles or protein have been reportedto induce IDO expression by macrophages and DCs (Boasso and
Shearer, 2007). IDO mediates immunosuppression and inﬂuences
the proliferation and effector functions of CD4+ T cells (Boasso
et al., 2007a), CD8+ T cells and natural killer cells. It also reduces
the number of antibody secreting plasma cells, which may con-
tribute to immune dysfunction in HIV-1 infected patients (Boasso
and Shearer, 2007). Plasmacytoid DCs behavior can be modulated
by IDO, resulting in impaired CD4+ T cell proliferative responses in
HIV-1 infected individuals (Boasso et al., 2007a) and a shift to Treg
cell differentiation (Manches et al., 2008). IDO-induced Treg cell
differentiation has been widely described (Boasso et al., 2007a, b;
Fig. 6. IDO inhibition compromises MDDCs-driven Treg-cell differentiation. (A) Scheme for suppression of T cell proliferation mediated by Treg cells. Immature MDDCs were
treated with histamine and/or HIV-1 and then co-cultured with CD4+CD45RA+ naïve T cells for 6 days in the presence or absence of 1-MT (200 μM). T-cells were then isolated
with anti-CD3 antibody-coated microbeads, and further co-cultured with CFSE-labeled allogeneic resting CD4+ T cells for an additional 3 days. (B) The suppression of
CFSE-labeled T cell proliferation stimulated with PHA-P was measured by ﬂow cytometry as described above. One representative from 3 donors is shown.
R.-R. Zhai et al. / Virology 442 (2013) 163–172170Favre et al., 2010; Jurgens et al., 2009; Matteoli et al., 2010). This
study adds more information that histamine can also induce IDO
expression in MDDCs, and this process requires histamine receptor
2-mediated signaling, but the molecular mechanism needs to be
further clariﬁed. Understanding the regulation of IDO expression
would help to elucidate immunosuppression in AIDS patients and
to better understand HIV-1 pathogenesis.
The effects of histamine/HIV-1 on DCs were also reﬂected by
altered cytokine secretion. The synergistic induction of IL-10 and
inhibition on IL-12 production provides another explanation for
immunosuppression during HIV-1 infection. The enhancement of
TGF-β may also contribute to Treg cell generation, and needs further
study. DCs play pivotal roles in viral pathogenesis. Mature splenic or
mesenteric myeloid DCs from SIV-infected Rhesus macaques
enhanced the capacity to induce Treg cells and might contribute to
Treg cells accumulation in lymphoid tissues during progressive
infection (Presicce et al., 2012). Given the critical role of DCs in
regulating host immunity and in HIV-1 pathogenesis, understanding
of the modulation of DC function may aid in developing new
immunoregulatory strategies to suppress viral infection.Materials and methods
Cells
Peripheral blood mononuclear cells (PBMCs) were purchased
from the Blood Center of Shanghai, China. CD14+ monocytes andCD4+ T cells were puriﬁed from PBMCs by anti-CD14 or anti-CD4
speciﬁc antibody-coated microbeads (Miltenyi Biotec). MDDCs
were generated from monocytes cultured in the presence of
25 ng/mL of interleukin-4 (IL-4) and granulocyte macrophage
colony-stimulating factor (GM-CSF) (R&D Systems) for 5 days.
CD4+ CD45RA+ naïve T cells were isolated by using a naïve CD4+
T cell isolation kit II (Miltenyi Biotec) according to manufacturer's
instructions. CD4+ T cells and naïve CD4+ T cells were cultured in
the presence of 20 IU/mL recombinant IL-2 (R&D Systems). The
human embryonic kidney cell line HEK293T was a kind gift from
Dr. Vineet Kewal Ramani (National Cancer Institute, USA).
Virus stocks
Pseudotyped single-cycle infectious HIV-1 stock, HIV-1/JRFL,
HIV-1/ADA and HIV-1/NL4-3, were generated by using calcium
phosphate-mediated co-transfection of HEK293T cells with the
plasmid pLAI-Δ-env-Luc and expression plasmids of envelope
glycoprotein, JRFL or ADA (HIV-1 CCR5-tropic), or NL4-3 (CXCR4-
tropic), as described previously (Shen et al., 2012). Harvested
supernatants of transfected cells containing HIV-1 particles were
ﬁltered and titrated with p24gag capture ELISA. Viral stock was
stored at −80 1C.
Flow cytometry
Cells were pre-incubated with human IgG (Invitrogen) for 10 min
to block Fc receptors. Monoclonal antibodies (McAbs) against the
R.-R. Zhai et al. / Virology 442 (2013) 163–172 171following human molecules were used for staining; clone numbers
and resources are given in parentheses: phycoerythrin (PE)-CD86
(IT2.2; eBioscience), PE-CD83 (HB15e; eBioscience), APC-Cy7-HLA-DR
(LN3, eBioscience), PerCP-Cy5.5-CD3 (OKT3, eBioscience), PE-CD4
(RPA-T4; eBioscience), APC-CD25 (BC96, eBioscience), FITC-Foxp3
(forkhead box P3) (236A/E7, eBioscience), APC-CD45RA (T6D11,
Miltenyi Biotec), Alexa Flours488-hIDO (IC6030G, R&D systems).
Intracellular Foxp3 staining was performed using Foxp3/Transcrip-
tional factor staining buffer set (eBioscience). Data analysis was
performed using FlowJo 7.6.1 Software (TreeStar Inc.).Reverse-transcription PCR and real-time PCR
Total RNAs from treated MDDCs was extracted using TRIzol
reagent (Life Technologies). RNA samples were reverse transcribed
to cDNA by using the ReverseAid™ First Strand cDNA synthesis Kit
(Fermentas) according to the manufacturer′s instructions. Real-
time PCR was performed using the Thunderbird SYBR qPCR Mix
(TOYOBO) with an initial denaturation step at 95 1C for 10 min,
ampliﬁcation with 40 cycles of denaturation (95 1C, 15 s), anneal-
ing (60 1C, 15 s), and extension (72 1C, 30 s); followed by a ﬁnal
extension at 72 1C for 6 min. Products were semi-quantiﬁed with
SYBR green I and normalized with β-actin. Real-time PCR was
performed on the ABI 7900HT Real-Time PCR system. These
primers are listed in (Table S1). Some PCR products were subjected
to 1.5% agarose gel electrophoresis, stained with ethidium bromide,
visualized, and photographed under UV illumination.Cytokine and IDO expression assays
Immature MDDCs were treated with histamine (10 μM) and/or
HIV-1/JRFL (4 ng of p24gag), or with gp120 glycosylated recombi-
nant protein fragment (amino acids 34–518) of HIV-1/JRFL (10 μg/mL)
(eENZYME) or with medium for 2 h. After treatment, cells were
washed and cultured for an additional 48 hours. The mRNA expres-
sion of cytokines of IL-6, IL-10, IL-12p40 and TGF-β was evaluated at
7 h post treatment by real-time PCR. Cytokine expression at 24 h
post treatment was measured by assay of proteins in the cell culture
supernatants. A ﬂow cytometric, bead-based multiplex immunoassay
kit (FlowCytomix™ Multiple Analyte Detection kit, eBioscience) was
used according to the manufacturer's guidelines.
MDDCs were treated with histamine, recombined TNF-α
(25 ng/mL) (R&D system) or lung β-tryptase (5 μg/mL) (Promega
Corp), HIV-1/JRFL (4 ng of p24gag) or indicated combinations.
IDO expression was measured at 7 h post-treatment for mRNA
expression, and at 24 h post-treatment for protein production by
intracellular staining. In some samples, MDDCs were pretreated
with pyrilamine (50 μM), cimetidine (50 μM), or thioperamide
(50 μM) (all from Sigma-Aldrich), respectively for 1 h. Cell viability
was evaluated with Propidium Iodide (PI, Invitrogen) staining and
measured by ﬂow cytometry.T cell proliferation assay
Immature MDDCs were treated with histamine (10 μM) and/or
HIV-1/JRFL (4 ng of p24gag) or medium for 2 h before washing and
culture for an additional 48 h. MDDCs were co-cultured with
allogenic CD4+ T cells in presence of IL-2 (at a 1:10 ratio of MDDCs:
T cells). The CD4+ T cells were pre-labeled with 3 μM of CFSE
(Carboxyﬂuorescein succinimidyl ester) (Invitrogen). After 6 days
of co-culture, T cell proliferation was assessed by ﬂow cytometric
detection of CFSE intensity, as described previously(St Gelais et al.,
2012).Naïve T cell differentiation and regulatory T cell assay
Immature MDDCs were treated with histamine (10 μM) and/or
HIV-1/JRFL (4 ng of p24gag) or medium for 2 h before washing and
culture for an additional 48 h. Then MDDCs were co-cultured with
allogeneic CD4+CD45RA+ naïve T cells (at a 1:20 ratio of MDDCs:
naïve T cells) for 6 days with or without 1-methyl-tryptophan (1-MT)
(200 μM) (Sigma-Aldrich). The proportion of CD4+CD25+Foxp3+cells,
deﬁned as Treg cells, was measured by ﬂow cytometry. A functional
assay of suppression of T cell proliferation by Treg cells was
performed in parallel. In brief, primed-T cells were puriﬁed from
DC-T cell mixtures using microbeads coated with anti-CD3 speciﬁc
antibody (Miltenyi Biotech). The puriﬁed T cells were co-cultured
with CFSE-labeled allogeneic resting CD4+ T cells at a 1:1 ratio
(primed T: CFSE-labeled T cell) in 96-well round bottom plates for an
additional 3 days. PHA-P (5 μg/mL) (Sigma-Aldrich) was used to
stimulate T cell proliferation; CFSE intensity was monitored by ﬂow
cytometry.
Statistical analysis
The paired sample t-test was used for statistical analyses.
Calculations were performed with SigmaStat 2.0 (Systat Software,
San Jose, CA, USA). A P-value o0.05 was considered to be
statistically signiﬁcant.Acknowledgments
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